233 South 10th Street
Suite 624 A
Philadelphia, PA 19107
(215) 503-4513
(215) 923-0249 fax
Suite 624 A
Philadelphia, PA 19107
(215) 503-4513
(215) 923-0249 fax
Most Recent Peer-reviewed Publications
- The decline and fall of the IGF-I receptor
- Nutrient restriction and radiation therapy for cancer treatment: When less is more
- The type 1 insulin-like growth factor receptor and resistance to DACH1
- Expression of Micro-RNA-145 is regulated by a highly conserved genomic sequence 3' to the pre-miR
- Regulation of microRNA-145 by growth arrest and differentiation
- Mutual interaction and reciprocal down-regulation between c-met and insulin receptor substrate-1
- MicroRNA, cell cycle, and human breast cancer
- The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms
- Mechanism of growth inhibition by microRNA 145: The role of the IGF-I receptor signaling pathway
- Growth inhibition by microRNAs that target the insulin receptor substrate-1
- Customizing the targeting of IGF-1 receptor
- AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells
- The insulin receptor substrate-1: A biomarker for cancer?
- Regulation of insulin receptor substrate-1 expression levels by caveolin-1
- The role of insulin receptor substrate-1 in the oncogenicity of simian virus 40 T antigen
- The role of insulin receptor substrate-1 in transformation by v-src
- Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes
- Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
- Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling
- Downregulation of the upstream binding factor1 by glycogen synthase kinase3β in myeloid cells induced to differentiate